Muralikrishna Tangirala, MS, MPH

home / authors / muralikrishna-tangirala-ms-mph

Articles

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

Melissa F. Thompson, BSc, MBA;Lei Chen, MD, PhD;Muralikrishna Tangirala, MS, MPH;Lina Asmar, PhD;Stephen E. Jones, MD

October 1st 2011

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com

Published: June 12th 2025 | Updated: June 16th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Published: June 10th 2025 | Updated: June 12th 2025

Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members

Published: June 2nd 2025 | Updated: June 11th 2025

NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care

Published: June 3rd 2025 | Updated: June 11th 2025

ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape

Published: May 30th 2025 | Updated: June 5th 2025

Emerging Data: Impacts of ROCKstar and AGAVE-201

Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com

Published: April 18th 2025 | Updated: April 21st 2025

Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Muralikrishna Tangirala, MS, MPH

Articles

Latest Updated Articles